LIVN LivaNova PLC

  1. Stocks
  2. Healthcare
  3. NASDAQ: LIVN

Price (delayed)

$80.99

Market cap

$3.97B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$7.8

Enterprise value

$4.35B

LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through ...

Highlights
LivaNova's revenue has increased by 9% from the previous quarter and by 4.2% YoY
The gross profit has grown by 9% from the previous quarter
The net income has plunged by 135% YoY but it is up by 8% from the previous quarter
LivaNova's EPS has shrunk by 134% YoY but it has increased by 8% QoQ
LivaNova's quick ratio has decreased by 44% YoY and by 40% QoQ
The equity has declined by 22% year-on-year and by 2.4% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.livanova.com
Peers: NARI MSON MMSI

Key stats

What are the main financial stats of LIVN
Market
Shares outstanding
49.02M
Market cap
$3.97B
Enterprise value
$4.35B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.8
Price to sales (P/S)
3.88
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.25
Earnings
Revenue
$1.02B
EBIT
-$332.2M
EBITDA
-$255.88M
Free cash flow
$59.06M
Per share
EPS
-$7.8
Free cash flow per share
$1.21
Book value per share
$21.3
Revenue per share
$20.88
TBVPS
$21.65
Balance sheet
Total assets
$2.4B
Total liabilities
$1.36B
Debt
$705.77M
Equity
$1.04B
Working capital
$106.85M
Liquidity
Debt to equity
0.68
Current ratio
1.15
Quick ratio
0.88
Net debt/EBITDA
-1.47
Margins
EBITDA margin
-25%
Gross margin
65.3%
Net margin
-37.2%
Operating margin
-28.8%
Efficiency
Return on assets
-15.7%
Return on equity
-33.2%
Return on invested capital
-30.8%
Return on capital employed
-19.6%
Return on sales
-32.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

LIVN stock price

How has the LivaNova stock price performed over time
Intraday
-0.74%
1 week
-3.46%
1 month
-1.28%
1 year
49.68%
YTD
22.32%
QTD
2.27%

Financial performance

How have LivaNova's revenue and profit performed over time
Revenue
$1.02B
Gross profit
$667.14M
Operating income
-$294.52M
Net income
-$379.61M
Gross margin
65.3%
Net margin
-37.2%
The net income has plunged by 135% YoY but it is up by 8% from the previous quarter
LIVN's net margin has dropped by 125% year-on-year but it is up by 15% since the previous quarter
The company's operating income has shrunk by 122% YoY and by 7% QoQ
LivaNova's operating margin has shrunk by 113% YoY

Growth

What is LivaNova's growth rate over time

Valuation

What is LivaNova stock price valuation
P/E
N/A
P/B
3.8
P/S
3.88
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.25
LivaNova's EPS has shrunk by 134% YoY but it has increased by 8% QoQ
The price to book (P/B) is 58% higher than the 5-year quarterly average of 2.4 and 27% higher than the last 4 quarters average of 3.0
The equity has declined by 22% year-on-year and by 2.4% since the previous quarter
The price to sales (P/S) is 14% higher than the last 4 quarters average of 3.4 and 11% higher than the 5-year quarterly average of 3.5
LivaNova's revenue has increased by 9% from the previous quarter and by 4.2% YoY

Efficiency

How efficient is LivaNova business performance
The return on equity has dropped by 189% year-on-year but it has grown by 2.1% since the previous quarter
The company's return on assets has shrunk by 142% YoY but it rose by 7% QoQ
LivaNova's return on sales has shrunk by 132% YoY but it has increased by 2.7% QoQ
The ROIC has plunged by 97% YoY and by 18% from the previous quarter

Dividends

What is LIVN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LIVN.

Financial health

How did LivaNova financials performed over time
The company's total assets is 77% higher than its total liabilities
The current ratio has dropped by 54% year-on-year and by 51% since the previous quarter
LivaNova's quick ratio has decreased by 44% YoY and by 40% QoQ
LIVN's debt is 32% smaller than its equity
LIVN's debt to equity is up by 31% year-on-year and by 3% since the previous quarter
The equity has declined by 22% year-on-year and by 2.4% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.